BioXcel Therapeutics, Inc. Skyrocketed
Mon, Aug 11, 2025 at 07:47 PM
BioXcel Therapeutics, Inc. (BTAI:NASDAQ) soared at $6.4, a gain of 58.4%. On Mon, Aug 11, 2025, BTAI:NASDAQ touched a New 2-Week High of $6.4. The stock got featured on our News Catalysts scanner on Mon, Aug 11, 2025 at 09:47 AM in the 'MISCELLANEOUS' category. From Mon, Jul 28, 2025, the stock recorded 70.00% Up Days and 54.55% Green Days
The stock spiked on Mon, Mar 03, 2025 at $6.83 with a volume of 146M+.
About BioXcel Therapeutics, Inc. (BTAI:NASDAQ)
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company which is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 138.1%
- Equillium, Inc. (EQ:NASDAQ), 78.88%
- Entero Therapeutics, Inc. (ENTO:NASDAQ), 66.46%
- Telos Corporation (TLS:NASDAQ), 62.61%
- International Money Express, Inc. (IMXI:NASDAQ), 60.56%
- CEA Industries Inc. (BNC:NASDAQ), 59.88%
- BioXcel Therapeutics, Inc. (BTAI:NASDAQ), 58.42%
- Kindly MD Inc. (NAKA:NASDAQ), 49.22%
- Aureus Greenway Holdings Inc. (AGH:NASDAQ), 46.97%
- Gamehaus Holdings Inc. (GMHS:NASDAQ), 46.73%